PCS
BCYC

Personal CFO Solutions’s Bicycle Therapeutics BCYC Stock Holding History

Personal CFO Solutions’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,455
Closed -$327K – 439
2022
Q1 		$327K Sell
7,455
-12
-0.2% -$560 0.06% 296
2021
Q4 		$455K Sell
7,467
-91
-1% -$5.02K 0.09% 214
2021
Q3 		$314K Buy
7,558
+273
+4% +$9.55K 0.06% 279
2021
Q2 		$221K Buy
+7,285
New +$220K 0.05% 384

Other funds holding BCYC

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Personal CFO Solutions's BCYC Position: Q2 2022 in Review

Personal CFO Solutions sold out of Bicycle Therapeutics (BCYC) in Q2 2022, closing a stake of 7,455 shares — an estimated $327K sold.

Personal CFO Solutions first reported a position in BCYC in Q2 2021 and held it in 4 quarters. The position peaked at $455K in Q4 2021. 81 funds tracked by Wall St. Rank hold BCYC as of Q2 2022.

  • Personal CFO Solutions reported no remaining Bicycle Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Personal CFO Solutions sold 7,455 Bicycle Therapeutics shares in Q2 2022, an estimated $327K.
  • Personal CFO Solutions first reported a position in Bicycle Therapeutics in Q2 2021 and held it in 4 quarters.
  • Personal CFO Solutions's Bicycle Therapeutics position peaked at $455K in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2022.

Based on Personal CFO Solutions's 13F filing for Q2 2022, filed 5 Aug 2022.